By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: AccuStem Sciences to Present at the Life Sciences Virtual Investor Forum September 18th
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > Health > AccuStem Sciences to Present at the Life Sciences Virtual Investor Forum September 18th
AccuStem Sciences to Present at the Life Sciences Virtual Investor Forum September 18th
Health

AccuStem Sciences to Present at the Life Sciences Virtual Investor Forum September 18th

GlobeNews Wire
Last updated: 16/09/2025 4:37 PM
GlobeNews Wire
Published: 16/09/2025
Share
SHARE

PHOENIX and LONDON, Sept. 16, 2025 (GLOBE NEWSWIRE) — AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, today announced that Wendy Blosser, CEO, will present live at the Life Sciences Virtual Investor Forum hosted by VirtualInvestorConferences.com, on September 18th, 2025.

DATE: September 18th
TIME: 2:30 pm EST
LINK: https://www.virtualinvestorconferences.com/wcc/eh/4814904/lp/5081546/accustem-sciences-inc-otcqb-acut
Available for 1×1 meetings: September 19-24

This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.

Ms. Blosser will be presenting on the exciting products in AccuStem’s portfolio and how they will address urgent unanswered clinical questions while returning significant value to investors.

It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.  

Learn more about the event at www.virtualinvestorconferences.com.

About AccuStem

AccuStem is a clinical stage diagnostics company dedicated to optimizing outcomes and quality of life for all patients with cancer. We plan to drive innovation in healthcare by offering proprietary molecular testing that addresses unmet clinical needs from cancer screening through treatment and monitoring. By interrogating novel disease pathways, such as tumor “stemness”, we believe our tools will help care teams better understand the biology of each patient’s cancer, leading to more informed decision making.

For more information, please visit www.accustem.com.

About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.

Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access.  Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.

CONTACTS:
AccuStem Sciences, Inc.
Jeff Fensterer
Chief Operations Officer
jeff@accustem.com

Virtual Investor Conferences
John M. Viglotti
SVP Corporate Services, Investor Access
OTC Markets Group
(212) 220-2221
johnv@otcmarkets.com

Vantage to Exhibit at Money Expo Colombia 2025
Immunocore to report second quarter 2025 financial results and host call on August 7, 2025
World Psoriasis Day 2025: IFPA Calls to Stop the Domino Effect of Psoriasis
HIMSS and Informa Markets Partner to Accelerate Digital Health Transformation with Co-Located Conferences in Malaysia for International Healthcare Week
JACK&JONES JUNIOR x NARUTO – THE BIGGEST DROP OF THE SEASON IS HERE
TAGGED:18thaccustemforuminvestorlifenewsOTC Markets:ACUTpresentsciencesseptembertheUS00442Y1010virtual
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
DERMALOG JENETRIC Introduces Mobile Palm Scanner LIVETOUCH PALM to the U.S. Market
News

DERMALOG JENETRIC Introduces Mobile Palm Scanner LIVETOUCH PALM to the U.S. Market

07/08/2025
Mark Cuban Foundation Announces Strategic Partnership with Turbo AI to Advance Educational Technology Access
Planting Hope for a Greener Tomorrow: World Environment Day Event at Manipal Hospital Malleshwaram Rooted for Environmental Awareness & Action
NYSE Content Advisory: Pre-Market Update + S&P 500 closes above 6,600 for first time
arcoris bio raises CHF 6.3 million seed round to advance next-generation biomarker technology for digital pathology
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?